Zoetis Inc (NYSE:ZTS) – Stock analysts at William Blair upped their Q1 2018 earnings per share (EPS) estimates for Zoetis in a report released on Thursday. William Blair analyst J. Kreger now expects that the company will post earnings of $0.69 per share for the quarter, up from their prior forecast of $0.62. William Blair also issued estimates for Zoetis’ Q2 2018 earnings at $0.72 EPS, Q3 2018 earnings at $0.79 EPS, Q4 2018 earnings at $0.79 EPS, FY2018 earnings at $3.00 EPS, FY2019 earnings at $3.31 EPS and FY2021 earnings at $4.01 EPS.
Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Thursday, November 2nd. The company reported $0.65 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.63 by $0.02. Zoetis had a return on equity of 62.39% and a net margin of 18.29%. The firm had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.32 billion. During the same quarter in the prior year, the firm posted $0.52 earnings per share. Zoetis’s revenue for the quarter was up 8.5% compared to the same quarter last year.
Shares of Zoetis (ZTS) opened at $75.39 on Friday. Zoetis has a one year low of $52.00 and a one year high of $75.69. The stock has a market capitalization of $36,740.00, a P/E ratio of 39.68, a price-to-earnings-growth ratio of 1.88 and a beta of 1.06. The company has a current ratio of 2.80, a quick ratio of 1.95 and a debt-to-equity ratio of 2.45.
A number of hedge funds have recently modified their holdings of ZTS. Commonwealth Bank of Australia grew its holdings in Zoetis by 8.9% in the 2nd quarter. Commonwealth Bank of Australia now owns 7,226 shares of the company’s stock worth $449,000 after buying an additional 593 shares in the last quarter. Franklin Resources Inc. grew its holdings in Zoetis by 7.7% in the 2nd quarter. Franklin Resources Inc. now owns 11,349 shares of the company’s stock worth $708,000 after buying an additional 816 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its holdings in Zoetis by 16.8% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,598 shares of the company’s stock worth $100,000 after buying an additional 230 shares in the last quarter. Riverhead Capital Management LLC grew its holdings in Zoetis by 34.0% in the 2nd quarter. Riverhead Capital Management LLC now owns 20,858 shares of the company’s stock worth $1,301,000 after buying an additional 5,287 shares in the last quarter. Finally, Raymond James Trust N.A. grew its holdings in Zoetis by 7.3% in the 2nd quarter. Raymond James Trust N.A. now owns 11,229 shares of the company’s stock worth $700,000 after buying an additional 764 shares in the last quarter. 93.19% of the stock is owned by institutional investors and hedge funds.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 1st. Investors of record on Friday, January 19th will be issued a $0.126 dividend. This represents a $0.50 dividend on an annualized basis and a yield of 0.67%. This is a positive change from Zoetis’s previous quarterly dividend of $0.11. The ex-dividend date of this dividend is Thursday, January 18th. Zoetis’s dividend payout ratio is 22.11%.
COPYRIGHT VIOLATION NOTICE: “William Blair Research Analysts Increase Earnings Estimates for Zoetis Inc (ZTS)” was first reported by Markets Daily and is owned by of Markets Daily. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.themarketsdaily.com/2018/01/14/william-blair-research-analysts-increase-earnings-estimates-for-zoetis-inc-zts.html.
Zoetis Company Profile
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.